By Rushika Fernandopulle
The following is a guest post from Rushika Fernandopulle, MD, MPP,
Co-Founder of Renaissance Health
. This is part of a continuing series of blog entries cross-posted here, on the Center for Information Therapy Blog, and the Health Affairs Blog
, the conference’s Media Partner in advance of the first-ever “Health 2.0 Meets Information Therapy” Conference
in Boston on April 22-23.
Rushika provides another physician perspective on the same question answered by John Halamka this week,
“How do we build Health 2.0 into the delivery system?” Both Rushika and
John will participate in a debate on this topic in Boston.
I am an internist who has been working for the last 5 years to
design, build, and test radically new models of delivering primary care
to improve experience, outcomes, and affordability of care. I currently
serve as Medical Director of one of our redesigned practices in
Atlantic City, NJ. Yesterday afternoon, Mr. Santos, a 53 year old
Hispanic doorman at a local hotel, came in to see me quite visibly
distraught. His prior primary care doctor had without asking him or
discussing the issue checked a PSA (Prostate Specific Antigen) as part
of his “routine” blood tests and the results were mildly positive
(6.5). He was told, “Your screen for Prostate cancer was positive, you
need to see a urologist right away to have it taken care of.” All he
heard, of course, was “cancer” and “positive” in the same sentence.
Before Mr. Santos had time to even form the first of the dozens of
questions he had, the doctor had already strode out the door. Over the
next few weeks, Mr. Santos went online to read about PSA and prostate
cancer (which yielded over 6 million pages on Google), and started
talking to his friends at work about the issue. What he surmised, quite
correctly, is that the way forward for him was not at all clear, and
that instead of finding answers he only had more (but better)
questions. What really was his chance of having Prostate Cancer? If he
did what really were the benefits of catching it so early? Were the
risks of the biopsies worth this benefit? What were his other choices?
Continue reading…